Tag: M.W=300-350

Wahbi, A. M. published the artcileSpectrophotometric analysis of binary mixtures of antazoline and naphazoline, Product Details of C17H20ClN3, the publication is Journal of Pharmaceutical Sciences (1978), 67(1), 140-1, database is CAplus and MEDLINE.

Simultaneous spectrophotometric determination of antazoline-HCl (I) [2508-72-7] and naphazoline-HNO₃ (II) [5144-52-5] in nasal drops involved dilution of 1 mL nasal drop solution to 50 mL with 0.1 N H₂SO₄, measuring the absorbancies at 281 and 295 nm, and applying the Glenn (1960), Cho (1970), and Pernarowski (1961) equations. Mean percentage recoveries for I were 99.5 (±1.05) and 99.7 (±1.24), resp., for 10 samples; for II they were 107.1 (±2.35) and 107.1 (±2.64), resp., for 10 samples. The relatively high percentage recoveries obtained for II were due to its low contribution to the absorption curve of the total mixture at the concentration used. Accuracy and precision for the determination of II was improved by applying the method of least squares.

Journal of Pharmaceutical Sciences published new progress about 2508-72-7. 2508-72-7 belongs to imidazoles-derivatives, auxiliary class Inhibitor,Immunology/Inflammation,Histamine Receptor, name is N-Benzyl-N-((4,5-dihydro-1H-imidazol-2-yl)methyl)aniline hydrochloride, and the molecular formula is C8H7BO2S, Product Details of C17H20ClN3.

Referemce:
https://en.wikipedia.org/wiki/Imidazole,
Imidazole | C3H4N2 – PubChem

Ali, Amir published the artcileStability indicating UHPLC-PDA assay for simultaneous determination of antazoline hydrochloride and naphazoline hydrochloride in ophthalmic formulations, Quality Control of 2508-72-7, the publication is Acta Chimica Slovenica (2017), 64(2), 332-341, database is CAplus and MEDLINE.

In the present study, a newly developed method based on ultrahigh performance liquid chromatog. (UHPLC) was optimized for the simultaneous determination of antazoline hydrochloride (ANZ) and naphazoline hydrochloride (NFZ) in ophthalmic formulations. Isocratic separation of ANZ and NFZ was performed at 40 °C with an ACE Excel 2 C18-PFP column (2 μm, 2.1 × 100 mm) at a flow rate of 0.6 mL min-1 whereas the mobile phase consisted of acetonitrile/phosphate buffer (60.40, volume/volume, pH 3.0) containing 0.5% triethylamine. Both analytes were detected at a wavelength of 285 nm and the injection volume was 1.0 μL. The overall run time per sample was 4.5 min with retention time of 0.92 and 1.86 min for NFZ and ANZ, resp. The calibration curve was linear from 0.500-100 μg mL-1 for ANZ and NFZ with a correlation coefficient ≥ 0.9981 while repeatability and reproducibility (expressed as relative standard deviation) were lower than 1.28 and 2.14%, resp. In comparison with high-performance liquid chromatog. (HPLC), the developed UHPLC method had remarkable advantages over HPLC as the run time was significantly reduced by 3.4-fold with a 5-fold decreased solvent consumption. Forced degradation studies indicated a complete separation of the analytes in the presence of their degradation products providing high degree of method specificity. The proposed UHPLC method was demonstrated to be simple and rapid for the determination of ANZ and NFZ in com. available ophthalmic formulations providing recoveries between 99.6 and 100.4%.

Acta Chimica Slovenica published new progress about 2508-72-7. 2508-72-7 belongs to imidazoles-derivatives, auxiliary class Inhibitor,Immunology/Inflammation,Histamine Receptor, name is N-Benzyl-N-((4,5-dihydro-1H-imidazol-2-yl)methyl)aniline hydrochloride, and the molecular formula is C17H20ClN3, Quality Control of 2508-72-7.

Referemce:
https://en.wikipedia.org/wiki/Imidazole,
Imidazole | C3H4N2 – PubChem